< Back to scientific publications

Report/Poster of Convention/Congress Act

Experience of Frosinone Simt in the management of patients treated with Daratumumab

Authors: D’Amico C. et al.

Date: 2019

Scope of interest: Transfusion Medicine




You may also be interested in:

Magazine 8.37

Recurrent partial seizures with ictal yawning as atypical presentation of Hashimoto’s encephalopathy (steroid-responsive encephalopathy associated with autoimmune thyroiditis).

Authors: S. Casciato, C. Di Bonaventura, L. Lapenta, J. Fattouch, G. Ferrazzano, M. Fanella, F. Di Fabio, M. Pasquini, M.A. Amendolea, M. Manfredi, M. Prencipe, A.T. Giallonardo

Date: 2011

Scope of interest: Epilepsy/autoimmune diseases of the CNS


Read details
Magazine 2.4

Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.

Authors: lionetti R

Date: May 2019

Scope of interest: infectious/hepatological


Read details
Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy


Read details